Evidence map›Paper›PMID 32395542›Full record

ReviewAnnals of translational medicine2020

The challenges in colorectal cancer management during COVID-19 epidemic.

Xianghai Ren, Baoxiang Chen, Yuntian Hong, Weicheng Liu, Qi Jiang, Jingying Yang, Qun Qian, Congqing Jiang

Abstract readReview
In one paragraph

Review in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Colon cancer treatment in Sweden during the COVID-19 pandemic: A nationwide register-based study.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2022
    Observational
  10. Article
  11. Article
  12. Bioinformatics andBioengineered · 2021
    Article
  13. Article
  14. Review
  15. Effects of COVID-19 pandemic on general surgical emergencies: are some emergencies really urgent? Level 1 trauma center experience.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xianghai RenDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Baoxiang ChenDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Yuntian HongDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Weicheng LiuDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Qi JiangDepartment of Pathology and Pathophysiology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.
Jingying YangDepartment of Anesthesia Surgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
Qun QianDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Congqing JiangDepartment of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been over 2 months since the start of the Coronavirus disease 2019 (COVID-19) outbreak. The epidemic stage of COVID-19 has brought great challenges to the diagnosis and management of colorectal cancer (CRC) patients. Symptoms, such as fever and cough caused by cancer, and the therapeutic process (including chemotherapy and surgery) should be differentiated from some COVID-19 related characteristics. Besides, clinical workers should not only consider the therapeutic strategy for cancer, but also emphasize COVID-19's prevention. Moreover, the detailed therapeutic regimens of CRC patients may be different from the usual. Also, treatment principles may various for CRC patients with or without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as patients with or without an emergency presentation. In this paper, we want to discuss the above-mentioned problems based on previous guidelines, the current working status and our experiences, to provide a reference for medical personnel.

Indexed as

2019 novel coronavirus disease (COVID-19)colorectal cancer (CRC)Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)

Identifiers

PMID32395542
PMCPMC7210180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.